Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs
Abstract Background Administrative healthcare claims data provide a mechanism for assessing and monitoring multiple sclerosis (MS) disease status across large, clinically representative “real-world” populations. The estimation of MS disease status using administrative claims can be a challenge, howe...
Main Authors: | Michael Munsell, Molly Frean, Joseph Menzin, Amy L. Phillips |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12883-017-0887-1 |
Similar Items
-
An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug
by: Munsell M, et al.
Published: (2016-12-01) -
Comorbidity in US patients with multiple sclerosis
by: Edwards NC, et al.
Published: (2018-02-01) -
Validity of Electronic Prescription Claims Records: A Comparison of Commercial Insurance Claims with Pharmacy Provider Derived Records
by: Bradley C. Martin, et al.
Published: (2014-01-01) -
Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims Population
by: Sara L. Gale, et al.
Published: (2019-11-01) -
Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies
by: Steven Simoens
Published: (2022-10-01)